Glucose Responsive Insulin Discovery and Validation RFA

JUVENILE DIABETES RESEARCH FOUNDATION- JDRF

Objecte

JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Letters of Intent (LOI) for the discovery and validation of novel glucose responsive insulin (GRI) drugs for better treatment of insulin-dependent diabetes mellitus (IDDM) and reducing the burden of daily management of the disease, particularly T1D.

Termini IISPV

Declaration of interest: IISPV’s deadline: 06/30/2014 (europa@iispv.cat) LOI: 07/4/2014 Full proposal: IISPV’s deadline: Application 09/01/2014

Termini Oficial

E/LOI Deadline 7/11/2014  – Application Deadline 09/19/2014

Estàs interessat?

Omple el següent formulari per rebre més informació: